COLOGNE, Germany (DecodeNews) — Scientists at the Max Planck Institute for Biology of Ageing reported Monday, Nov. 16, 2026, in Nature Communications that vitamin B12 largely reversed developmental abnormalities in roundworms carrying a genetic mutation linked to Verheij syndrome.
RNA splicing defect disrupts vitamin metabolism
Verheij syndrome is a rare human genetic disorder causing developmental delays, impaired growth, and short stature due to mutations in genes governing RNA splicing—the cellular process that edits messenger RNA to produce proteins. Using genetic screens in C. elegans roundworms, researchers found the mutation disrupted metabolic pathways dependent on vitamin B12, slowing growth and stunting worm size.
"We were surprised to find that a change in a fundamental process of RNA processing had such a targeted effect on vitamin B12-dependent metabolism," said first author Jonathan Kölschbach. "Even more exciting was that we were able to largely correct the consequences of this change in the worm model using vitamin B12."
Human patient samples show parallel metabolic shifts
Collaborating with neuropediatrician Hormos Dafsari at University Hospital Cologne, the team analyzed public human cell datasets and blood samples from Verheij syndrome patients, uncovering similar metabolic changes. Lead author Adam Antebi noted researchers have not yet established whether vitamin B12 supplementation improves symptoms in human patients.


